An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

ClinicalTrials.gov ID: NCT01666119

Public ClinicalTrials.gov record NCT01666119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 12, 2026, 4:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects (BNX-201)

Study identification

NCT ID: NCT01666119
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: BioDelivery Sciences International; Industry
Enrollment: 249 participants

Conditions and interventions

Conditions

Opioid Dependence

Interventions

BEMA Buprenorphine NX films Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2012
Primary completion: Dec 31, 2012
Completion: Dec 31, 2012
Last update posted: Apr 3, 2017

2012 – 2013

United States locations

U.S. sites: 10
U.S. states: 7
U.S. cities: 10

Facility	City	State	ZIP	Site status
Not listed	Birmingham	Alabama	35215	—
Not listed	Haleyville	Alabama	35565	—
Not listed	Jacksonville	Florida	32256	—
Not listed	Maitland	Florida	32751	—
Not listed	North Miami	Florida	33161	—
Not listed	Prairie Village	Kansas	66206	—
Not listed	Baltimore	Maryland	21201	—
Not listed	Fall River	Massachusetts	02720	—
Not listed	Belvidere	New Jersey	07823	—
Not listed	Salt Lake City	Utah	84106	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01666119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 3, 2017 · Synced May 12, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01666119 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →